3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
13
Oropharyngeal Neoplasms
11
Lung Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Mouth Neoplasms
8
Laryngeal Neoplasms
8
Carcinoma
8
Urinary Bladder Neoplasms
6
Nasopharyngeal Carcinoma
6
Hypopharyngeal Neoplasms
6
Pancreatic Neoplasms
5
Mesothelioma, Malignant
5
Uterine Cervical Neoplasms
4
Ovarian Neoplasms
4
Medulloblastoma
4
Ganglioneuroblastoma
4
Gallbladder Neoplasms
4
Neuroblastoma
3
Lymphoid Interstitial Pneumonia
3
Cholangiocarcinoma
3
Triple Negative Breast Neoplasms
2
Salivary Gland Neoplasms
2
Paranasal Sinus Neoplasms
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Interventions
Doxorubicin
7
pembrolizumab
5
Radiotherapy
5
Specimen Handling
4
Radiation
4
Magnetic Resonance Spectroscopy
4
palbociclib
3
eribulin
3
abemaciclib
3
Ifosfamide
3
Biopsy
3
pazopanib
2
brigimadlin
2
Immunoglobulin G
2
zimberelimab
1
toripalimab
1
talimogene laherparepvec
1
silmitasertib
1
selinexor
1
ribociclib
1
peposertib
1
pemigatinib
1
olaratumab
1
olaparib
1
mirdametinib
1
liposomal doxorubicin
1
lenvatinib
1
enzalutamide
1
durvalumab
1
cemiplimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liposarcoma
×
1,2-diaminocyclohexaneplatinum II citrate
×
1 year
×
Clear all
No trials found.